Goldman Sachs Group Inc. raised its stake in shares of Nutraceutical International Corporation (NASDAQ:NUTR) by 65.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,243 shares of the company’s stock after buying an additional 5,222 shares during the period. Goldman Sachs Group Inc. owned about 0.14% of Nutraceutical International Corporation worth $413,000 as of its most recent filing with the SEC.
Several other institutional investors have also made changes to their positions in the stock. Acadian Asset Management LLC raised its position in shares of Nutraceutical International Corporation by 10.8% in the first quarter. Acadian Asset Management LLC now owns 275,642 shares of the company’s stock valued at $8,589,000 after buying an additional 26,881 shares in the last quarter. First Quadrant L P CA acquired a new position in shares of Nutraceutical International Corporation during the first quarter valued at $301,000. Strs Ohio raised its position in shares of Nutraceutical International Corporation by 3.1% in the first quarter. Strs Ohio now owns 20,000 shares of the company’s stock valued at $623,000 after buying an additional 600 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Nutraceutical International Corporation by 4.8% in the first quarter. Bank of New York Mellon Corp now owns 48,139 shares of the company’s stock valued at $1,499,000 after buying an additional 2,206 shares in the last quarter. Finally, Parametric Portfolio Associates LLC raised its position in shares of Nutraceutical International Corporation by 55.8% in the first quarter. Parametric Portfolio Associates LLC now owns 31,981 shares of the company’s stock valued at $996,000 after buying an additional 11,459 shares in the last quarter. Hedge funds and other institutional investors own 75.72% of the company’s stock.
Nutraceutical International Corporation (NASDAQ:NUTR) remained flat at $41.80 during midday trading on Wednesday. The stock had a trading volume of 193,896 shares. The stock’s 50-day moving average price is $41.77 and its 200 day moving average price is $36.55. Nutraceutical International Corporation has a 52-week low of $24.92 and a 52-week high of $42.45. The stock has a market cap of $386.48 million, a PE ratio of 27.00 and a beta of 0.49.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://stocknewstimes.com/2017/08/23/nutraceutical-international-corporation-nutr-position-boosted-by-goldman-sachs-group-inc.html.
Separately, BidaskClub lowered Nutraceutical International Corporation from a “hold” rating to a “sell” rating in a research note on Saturday, July 8th.
About Nutraceutical International Corporation
Nutraceutical International Corporation is an integrated manufacturer, marketer, distributor and retailer of nutritional supplements and other natural products. The Company’s products include vitamins and minerals; herbs; specialty formulas; personal care products; liquid nutritional products; homeopathics; functional foods, and other products.
Receive News & Ratings for Nutraceutical International Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutraceutical International Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
